Background: The Affordable Medicines Facility – malaria (AMFm) is a subsidy mechanism to lower the price of, and hence increase access to, the best antimalarial medicines, artemisinin-based combination therapies (ACTs). While the AMFm stipulates that only quality-approved products are eligible...

Phase 1 of the Affordable Medicines Facility for malaria (AMFm) is a $225 million initiative that was launched in 2010 in an effort to increase access to safe and effective artemisinin-based combination therapies (ACTs) by dramatically lowering their price with a global subsidy. The AMFm also...

Malaria kills millions of people each year and hundreds of millions more suffer chronic illness. Economic development is inhibited and poverty is perpetuated. Tren and Bate argue that action against malaria is over-centralised and narrowly focused, ignoring local conditions and concerns. Health...

With the entire US budget on the chopping block, small-ticket items such as the US global health budget — a total expenditure of around $8.6 billion — will necessarily attract less attention than sequestration of the defense budget or cuts to Social Security. But while America’s global...

The Global Fund to Fight AIDS, Tuberculosis and Malaria recently approved an innovative initiative called the Affordable Medicines Facility for malaria (AMFm), to increase access to artemisinin-based combination therapies (ACTs) for the treatment of malaria. The AMFm emerged from proposals in...